13F

Stock

Iovance Biotherapeutics, Inc.

IOVA · held by 2 managers

Reported value

$7.2M

Holders

2

+0 new · −0 exited

Holders’ est. mark

$2.86M

Price effect on 2 books still in the name

Largest holder

$6.8M

BARCLAYS PLC

Holder count by quarter

Who holds it

Notable only
InvestorSharesValueEst. markChange
BARCLAYS PLC836.2K$6.8M$2.71MAdded$3.35M
Leonteq Securities AG50K$406.5K$148.3KAdded$218.1K

Positions as of Q4 2023. 13F filings arrive up to 45 days after quarter-end and omit shorts. Values are quarter-end marks, as filed. Estimated mark is the price effect on shares still held — not realized P&L or investment advice.